These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3146159)

  • 1. [Economic criteria in assessing the efficacy of the fight against cancer].
    Diatchenko OT; Shabashova NIa
    Vopr Onkol; 1988; 34(12):1411-21. PubMed ID: 3146159
    [No Abstract]   [Full Text] [Related]  

  • 2. [Economic aspects of the fight against cancer].
    Shubin BM; Rutgaĭzer VM; Khadzhiev MA; Aleksandrorva LA
    Sov Med; 1984; (5):64-8. PubMed ID: 6431616
    [No Abstract]   [Full Text] [Related]  

  • 3. [Economic aspects of cancer control measures].
    Chissov VI; Rutgaĭzer VM; Shubin BM; Khadzhiev MA; Aleksandrova LA
    Vopr Onkol; 1983; 29(11):8-13. PubMed ID: 6649545
    [No Abstract]   [Full Text] [Related]  

  • 4. [Medical and economic aspects of the use of computers in oncological screening].
    Stranadko EF; Aleksandrova LA; Osmolovskiĭ MM
    Sov Med; 1986; (8):67-70. PubMed ID: 3775511
    [No Abstract]   [Full Text] [Related]  

  • 5. [Economic aspects of detecting oncological patients in prophylactic screenings of the population].
    Shubin BM; Rutgaĭzer VM; Khadzhiev MA; Konstantinov VM; Vinokur ML
    Vopr Onkol; 1981; 27(1):3-8. PubMed ID: 7456441
    [No Abstract]   [Full Text] [Related]  

  • 6. The futility and lack of cost-effectiveness in screening for cancer.
    Handler S
    Minn Med; 1992 Dec; 75(12):13-6. PubMed ID: 1470083
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
    Knudsen AB; McMahon PM; Gazelle GS
    J Clin Oncol; 2007 Jan; 25(2):203-8. PubMed ID: 17210941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicine's battle with cancer. Screening still key element of armamentarium.
    Long HJ
    Minn Med; 1992 Dec; 75(12):17-9. PubMed ID: 1470084
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the cost-effectiveness of cancer screening promotion.
    Andersen MR; Urban N; Ramsey S; Briss PA
    Cancer; 2004 Sep; 101(5 Suppl):1229-38. PubMed ID: 15316909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer in health economics].
    Delande G
    Bull Cancer Radiother; 1994; 81(2):91-8. PubMed ID: 7702899
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers.
    Baron RC; Rimer BK; Coates RJ; Kerner J; Mullen PD; Chattopadhyay S; Briss PA;
    Am J Prev Med; 2008 Jul; 35(1 Suppl):S26-33. PubMed ID: 18541185
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of cancer screening in end-stage renal disease.
    Chertow GM; Paltiel AD; Owen WF; Lazarus JM
    Arch Intern Med; 1996 Jun; 156(12):1345-50. PubMed ID: 8651845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and cost-effectiveness of colorectal cancer prevention and therapy.
    Schrag D; Weeks J
    Semin Oncol; 1999 Oct; 26(5):561-8. PubMed ID: 10528905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of cost-effective early detection programs into the health services of developing countries.
    Sankaranarayanan R
    Cancer; 2000 Aug; 89(3):475-81. PubMed ID: 10931445
    [No Abstract]   [Full Text] [Related]  

  • 16. Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions?
    Wang PE; Wang TT; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S54-8. PubMed ID: 17227644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs and effects of alternative screening programs against cervical cancer].
    Gyrd-Hansen D; Hølund B; Andersen P
    Ugeskr Laeger; 1996 Aug; 158(35):4912-5. PubMed ID: 8801698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and economic implications of cancer in the United States.
    Rice DP; Hodgson TA
    Vital Health Stat 3 Anal Stud; 1981 Mar; (20):1-43. PubMed ID: 6908994
    [No Abstract]   [Full Text] [Related]  

  • 19. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
    Krahn MD; Coombs A; Levy IG
    CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cost of cancer in France: macroeconomic and microeconomic approaches, evolution towards a prospective payment system].
    Perrier L; Borella L; Philip T
    Bull Cancer; 2003 Nov; 90(11):1005-9. PubMed ID: 14706905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.